Progressing Group B Streptococcal vaccines (PROGRESS Study) metadata

Data dictionaries for the PROGRESS study. The PROGRESS Study is a multi-site sero-epidemiological study of Group B Streptoccus, colonisation, preterm, stillbirth, neonatal infection and neurodevelopmental outcomes following infection based in Kampala, Uganda. The study had 2 entry points: Birth Cohort – women were recruited in labour and they and their infants (if liveborn) were followed until 3 months of age. Active Surveillance Cohort – any infant with signs or symptoms of infection under 3 months of age was recruited to the study for investigation of causes of infection. The full protocol is published here: https://pubmed.ncbi.nlm.nih.gov/33299966/